Skip to main content
Log in

Diagnostic relevance of fibronectin in cryoprecipitates

  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Fibronectin is a known component of plasma cryoprecipitates. It is seen in cryoglobulins from patients with monoclonal gammopathies and also from rheumatoid arthritis, and patients with systemic lupus erythematosus and other connective tissue diseases. We evaluated the clinical relevance of measures of cryoprecipitable fibronectin from the sera of 88 patients with rheumatic diseases and 27 healthy controls. There were 28 patients with rheumatoid arthritis, 19 with systemic vasculitis, 5 with cutaneous vasculitis, and 36 with a systemic connective tissue disorder. We measured total and cryoprecipitable fibronectin and for comparison immunoglobulins G, A, and M and complement C3 and C4. Cryoprecipitable fibronectin was detected in 33% control sera and 42% patient sera. The mean levels were higher in the sera of patients in all diagnostic groups. The highest levels were seen in rheumatoid patients with systemic disease, systemic vasculitis, and connective tissue diseases. The presence of cryoprecipitable fibronectin was related to the clinical activity of systemic vasculitis; none of the 6 patients with clinically inactive vasculitis had detectable fibronectin in their cryoprecipitates; but it was seen in 7 to 13 cases with active vasculitis. There were only weak relationships between cryoprecipitable fibronectin and immunoglobulin and complement levels in cryoprecipitates. We conclude that routinely measuring fibronectin levels in cryoprecipitates is generally of doubtful diagnostic value. However, it appears to be a useful marker of the clinical activity of systemic vasculitis and we recommend its use in the laboratory assessment of vasculitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anderson B, Rucker M, Entwistle R, Schmid FR, Wood GW (1981) Plasma fibronectin is a component of cryoglobulins from patients with connective tissue and other diseases. Ann Rheum Dis 40: 50–54

    Google Scholar 

  2. Wood G, Rucker M, Davies JW, Entwistle R, Anderson B (1980) Interaction of plasma fibronectin with selected cryoglobulins. Clin Exp Immunol 40: 358–364

    Google Scholar 

  3. Scott DL, Almond TJ, Naqvi SNH, Lea DJ, Stone R, Walton KW (1982) The significance of fibronectin in cryoprecipitation in rheumatoid arthritis and other disorders. J Rheumatol 9: 514–518

    Google Scholar 

  4. Beaulieu AD, Valet JP, Strevey J (1981) The influence of fibronectin in cryoprecipitate formation in rheumatoid arthritis and systemic lupus erythematous. Arthritis Rheum 24: 1383–1388

    Google Scholar 

  5. Carsons S, Lavietes BB, Diamond HS (1983) Factors influencing the incorporation of fibronectin into synovial fluid cryoprotein. J Lab Clin Med 102: 722–731

    Google Scholar 

  6. Villar M, Garcia-Bragado F, Jorem J, Blosca M, Antolin M, Rodrigo MJ, Schwartz S (1985) Cryoglobulinaemia and fibronectin. Acta Haematol 74: 161–163

    Google Scholar 

  7. Ferraccioli G (1986) Cryoprecipitation. In vitro studies on fibronectin as an independant cryoprecipitagogue. Ric Clin Lab 16: 315–320

    Google Scholar 

  8. Herbert KE, Jeffery E, Scott DL (1988) Interference by fibronectin in the crithidia inciliae tests for dsDNA antibodies in systemic lupus erythematosus. Br J Rheumatol [Suppl] 27: 21

    Google Scholar 

  9. Scott DGI, Bacon PA, Allen C, Elson CJ, Wallington TJ (1981) IgG rheumatoid factor, complement, and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 43: 54–63

    Google Scholar 

  10. Scott DGI, Bacon PA, Elliot PJ, Tribe CR, Wallington TJ (1982) Systemic vasculitis in a district general hospital 1972–1978: clinical and laboratory features, classification, and prognosis in 80 cases. Q J Med 51: 292–311

    Google Scholar 

  11. Scott DGI, Blake DR, Blann A, Salmon M, Brailsford S, Winyard P, Bacon PA (1984) The role of lymphocytes and serum factors in vasculitic diseases. Ann Rheum Dis 43: 116

    Google Scholar 

  12. Scott DL, Farr M, Crockson AP, Walton KW (1982) Synovial fluid and plasma fibronectin levels in rheumatoid arthritis. Clin Sci 62: 71–76

    Google Scholar 

  13. Morrison PR, Edsall JT, Miller SG (1948) Preparation and properties of serum and plasma proteins. XVIII Separation of purified fibrinogen from fraction I of human plasma. J Ann Chem Soc 70: 3103–3108

    Google Scholar 

  14. Edsall JT, Gilbert GA, Scheraga HA (1955) The non-clotting component of the human plasma fraction I-1 (cold insoluble globulin). J Am Chem Soc 77: 157–161

    Google Scholar 

  15. Stathakis NE, Mosesson MW, Chen AB, Galanakis DK (1978) Cryoprecipitation of fibrin-fibrinogen complexes induced by cold insoluble globulin of plasma. Blood 51: 1211–1222

    Google Scholar 

  16. Stathakis NE, Mosesson MW (1977) Interactions among heparin, cold insoluble globulin and fibrinogen in the formation of the heparin-precipitable fraction. J Clin Invest 60: 855–865

    Google Scholar 

  17. Garelli S, Eroni PL, Montani F, Inveruizzi F (1986) Fibronectin and cryoprecipitation. Ric Clin Lab 16: 321–326

    Google Scholar 

  18. Menzell EJ, Smollen JS, Liotta L, Reid KBM (1982) Interaction of fibronectin with Clq and its collagen-like fragment (CLF). FEBS Lett 129: 188–192

    Google Scholar 

  19. Hautanen A, Keski-Oja J (1983) Affinity of myeloma IgG proteins for fibronectin. Clin Exp Immunol 53: 233–138

    Google Scholar 

  20. Carter SD, Scott DL, Elson CJ (1986) Fibronectin associated with immunoglobulin aggregates in sera and synovial fluid in rheumatoid arthritis. Br J Rheumatol 25: 353–358

    Google Scholar 

  21. Herbert KE, Coppock JS, Griffiths AM, Williams A, Robinson MW, Scott DL (1987) Fibronectin and immune complexes in rheumatic diseases. Ann Rheum Dis 46: 734–740

    Google Scholar 

  22. Sorvillo J, Gigli I, Realstein E (1986) Fibronectin binding to Clq associated with antigen-antibody complexes in EDTA treated plasma. Scand J Immunol 23: 153–160

    Google Scholar 

  23. Seeling R, Pott G, Seeling HP, Lichr H, Metzger P, Waldherr R (1984) Virus-binding activity of fibronectin: masking of hepatitis A virus. J Virol Methods 8: 335–347

    Google Scholar 

  24. Inman RD, Hodge M, Johnston MEA, Wright J, Heathcote J (1986) Arthritis, vasculitis, and cryoglobulinaemia associated with relapsing hepatitis A virus infection. Ann Intern Med 105: 700–703

    Google Scholar 

  25. Savage COS, Ng YC (1986) Aetiology and pathogenesis of major systemic vasculitides. Postgrad Med J 62: 627–636

    Google Scholar 

  26. Ronco P, Verroust P, Mignon F, Kourilsky O, Vanhilte P, Meyrier A, Mery JP, Mord-Maroger L (1983) Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis. A report of 43 patients and 51 renal biopsies. Q J Med 52: 212–223

    Google Scholar 

  27. Tzioufas AG, Manoussakis MN, Costello R, Silis M, Papadopoulos NM, Moutsopoulos HM (1986) Cryoglobulinaemia in autoimmune rheumatic diseases: evidence of circulating monoclonal cryoglobulins in patients with Sjögren's syndrome. Arthritis Rheum 29: 1098–1104

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robinson, M.W., Walton, K.W., Scott, D.G.I. et al. Diagnostic relevance of fibronectin in cryoprecipitates. Rheumatol Int 10, 81–84 (1990). https://doi.org/10.1007/BF02274788

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02274788

Key words

Navigation